Shenandoah Therapeutics is a biotechnology company.
Shenandoah Therapeutics has raised $20.0M in total funding. The most recent round was Seed. The last funding was announced in June 2025.
Shenandoah Therapeutics's investors include Highlight Capital, Samsara BioCapital.
Shenandoah Therapeutics is headquartered in South San Francisco, United States.
Shenandoah Therapeutics is a biotechnology company.
Shenandoah Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Shenandoah Therapeutics — Funding & Investors." VCBacked, June 19, 2025, https://www.vcbacked.co/company/shenandoah-therapeutics. Accessed November 13, 2026.
VCBacked. (2025). Shenandoah Therapeutics — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/shenandoah-therapeutics
{{cite web |title=Shenandoah Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/shenandoah-therapeutics |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Shenandoah Therapeutics? Request a listing update